Literature DB >> 20167629

Experimental impact of aspirin exposure on rat intestinal bacteria, epithelial cells and cell line.

Raj K Upreti1, A Kannan, A B Pant.   

Abstract

Aspirin, a commonly used therapeutic non-steroidal anti-inflammatory drug (NSAID) is known to cause gastric mucosal damage. Intestinal bacteria having a regulatory effect on intestinal homeostasis play significant role in NSAID-induced intestinal injury. Bacteria and specific cell lines are considered to be suitable for toxicity screening and testing of chemicals. Therefore, to evaluate and compare in vitro toxicity, cultures of rat intestinal epithelial cells (IEC), isolated bacteria and IEC-6 cell line were assessed for viability, morphometric analysis, membrane transport enzymes and structural constituents for membrane damage, dehydrogenase activity test for respiratory and energy producing processes and esterase activity test for intra- and extra-cellular degradation, following the post exposure to aspirin (0-50 µg mL(- 1)). Similar pattern of dose-dependent changes in these parameters were observed in three types of cells. Similar in situ effects on IEC validated the in vitro findings. These findings indicate that higher aspirin concentrations may alter cellular functions of IEC and gut bacteria. Furthermore, results suggest that gut bacteria and IEC-6 cell line can be used for the initial screening of gastrointestinal cellular toxicity caused by NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167629     DOI: 10.1177/0960327110363333

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  3 in total

1.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

2.  Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk.

Authors:  Anna E Prizment; Christopher Staley; Guillaume C Onyeaghala; Sithara Vivek; Bharat Thyagarajan; Robert J Straka; Ryan T Demmer; Dan Knights; Katie A Meyer; Aasma Shaukat; Michael J Sadowsky; Timothy R Church
Journal:  Aliment Pharmacol Ther       Date:  2020-08-08       Impact factor: 8.171

3.  The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.

Authors:  Luis Vitetta; Samantha Coulson; Anthony W Linnane; Henry Butt
Journal:  Pathogens       Date:  2013-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.